Patients with refractory metastatic colorectal cancer could use trifluridine/tipiracil (TAS-102) plus bevacizumab as a cost effective third line treatment in China but the same was not found in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback